View in EDS HTML Full Text PDF Full Text

Prevalence, mechanisms, and management of cancer-related cognitive impairment.

Saved in:
Bibliographic Details
Title: Prevalence, mechanisms, and management of cancer-related cognitive impairment.
Authors: Janelsins, Michelle C. (AUTHOR), Kesler, Shelli R. (AUTHOR), Ahles, Tim A. (AUTHOR), Morrow, Gary R. (AUTHOR)
Source: International Review of Psychiatry. Feb2014, Vol. 26 Issue 1, p102-113. 12p.
Subjects: Tumor treatment, Cognition disorders treatment, Attention, Brain, Cancer chemotherapy, Cognition disorders, Immune system, Memory, Thought & thinking, Tumors, Disease management, Disease complications, Genetics
Abstract: This review summarizes the current literature on cancer-related cognitive impairment (CRCI) with a focus on prevalence, mechanisms, and possible interventions for CRCI in those who receive adjuvant chemotherapy for non-central nervous system tumours and is primarily focused on breast cancer. CRCI is characterized as deficits in areas of cognition including memory, attention, concentration, and executive function. Development of CRCI can impair quality of life and impact treatment decisions. CRCI is highly prevalent; these problems can be detected in up to 30% of patients prior to chemotherapy, up to 75% of patients report some form of CRCI during treatment, and CRCI is still present in up to 35% of patients many years following completion of treatment. While the trajectory of CRCI is becoming better understood, the mechanisms underlying the development of CRCI are still obscure; however, host characteristics, immune dysfunction, neural toxicity, and genetics may play key roles in the development and trajectory of CRCI. Intervention research is limited, though strategies to maintain function are being studied with promising preliminary findings. This review highlights key research being conducted in these areas, both in patient populations and in animals, which will ultimately result in better understanding and effective treatments for CRCI. [ABSTRACT FROM AUTHOR]
Copyright of International Review of Psychiatry is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 94628370
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Prevalence, mechanisms, and management of cancer-related cognitive impairment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Janelsins%2C+Michelle+C%2E%22">Janelsins, Michelle C.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kesler%2C+Shelli+R%2E%22">Kesler, Shelli R.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ahles%2C+Tim+A%2E%22">Ahles, Tim A.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Morrow%2C+Gary+R%2E%22">Morrow, Gary R.</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22International+Review+of+Psychiatry%22">International Review of Psychiatry</searchLink>. Feb2014, Vol. 26 Issue 1, p102-113. 12p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Tumor+treatment%22">Tumor treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Cognition+disorders+treatment%22">Cognition disorders treatment</searchLink><br /><searchLink fieldCode="DE" term="%22Attention%22">Attention</searchLink><br /><searchLink fieldCode="DE" term="%22Brain%22">Brain</searchLink><br /><searchLink fieldCode="DE" term="%22Cancer+chemotherapy%22">Cancer chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Cognition+disorders%22">Cognition disorders</searchLink><br /><searchLink fieldCode="DE" term="%22Immune+system%22">Immune system</searchLink><br /><searchLink fieldCode="DE" term="%22Memory%22">Memory</searchLink><br /><searchLink fieldCode="DE" term="%22Thought+%26+thinking%22">Thought & thinking</searchLink><br /><searchLink fieldCode="DE" term="%22Tumors%22">Tumors</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+management%22">Disease management</searchLink><br /><searchLink fieldCode="DE" term="%22Disease+complications%22">Disease complications</searchLink><br /><searchLink fieldCode="DE" term="%22Genetics%22">Genetics</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: This review summarizes the current literature on cancer-related cognitive impairment (CRCI) with a focus on prevalence, mechanisms, and possible interventions for CRCI in those who receive adjuvant chemotherapy for non-central nervous system tumours and is primarily focused on breast cancer. CRCI is characterized as deficits in areas of cognition including memory, attention, concentration, and executive function. Development of CRCI can impair quality of life and impact treatment decisions. CRCI is highly prevalent; these problems can be detected in up to 30% of patients prior to chemotherapy, up to 75% of patients report some form of CRCI during treatment, and CRCI is still present in up to 35% of patients many years following completion of treatment. While the trajectory of CRCI is becoming better understood, the mechanisms underlying the development of CRCI are still obscure; however, host characteristics, immune dysfunction, neural toxicity, and genetics may play key roles in the development and trajectory of CRCI. Intervention research is limited, though strategies to maintain function are being studied with promising preliminary findings. This review highlights key research being conducted in these areas, both in patient populations and in animals, which will ultimately result in better understanding and effective treatments for CRCI. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of International Review of Psychiatry is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=94628370
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3109/09540261.2013.864260
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 102
    Subjects:
      – SubjectFull: Tumor treatment
        Type: general
      – SubjectFull: Cognition disorders treatment
        Type: general
      – SubjectFull: Attention
        Type: general
      – SubjectFull: Brain
        Type: general
      – SubjectFull: Cancer chemotherapy
        Type: general
      – SubjectFull: Cognition disorders
        Type: general
      – SubjectFull: Immune system
        Type: general
      – SubjectFull: Memory
        Type: general
      – SubjectFull: Thought & thinking
        Type: general
      – SubjectFull: Tumors
        Type: general
      – SubjectFull: Disease management
        Type: general
      – SubjectFull: Disease complications
        Type: general
      – SubjectFull: Genetics
        Type: general
    Titles:
      – TitleFull: Prevalence, mechanisms, and management of cancer-related cognitive impairment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Janelsins, Michelle C.
      – PersonEntity:
          Name:
            NameFull: Kesler, Shelli R.
      – PersonEntity:
          Name:
            NameFull: Ahles, Tim A.
      – PersonEntity:
          Name:
            NameFull: Morrow, Gary R.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2014
              Type: published
              Y: 2014
          Identifiers:
            – Type: issn-print
              Value: 09540261
          Numbering:
            – Type: volume
              Value: 26
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: International Review of Psychiatry
              Type: main
ResultId 1